Woke Pfizer Policy Prohibits Whites and Asians from Applying for Fellowship

Drug giant Pfizer says its top-level “Breakthrough Fellowship Program” that prohibits whites and Asians from applying is a “Bold Move” that promotes “a more inclusive workplace,” and will have Pfizer led by “a new generation” of minority fellows by 2025.

“One of Pfizer’s Bold Moves is to create a workplace for all, and we are committed to increasing diversity by fostering a more inclusive workplace,” says Pfizer, one of the Big Pharma companies at the center of the controversial COVID-19 vaccines.

Read More

Moderna Suing Pfizer for COVID-19 Vaccine Patent Infringement

Moderna is filing patent infringement lawsuits against Pfizer and BioNTech in U.S. district court and German regional court Friday in connection with the two companies’ COVID-19 vaccine, Moderna announced.

Moderna alleges Pfizer and BioNTech’s Comirnaty vaccine breaches its mRNA technology patents submitted between 2010 and 2016. It claims they developed their vaccine by copying the technology Moderna used to make its mRNA COVID-19 vaccine, Spikevax.

Read More

Report: 44 Percent of Pregnant Women in Pfizer Vaccine Trial Lost Their Babies

More than 40 percent of pregnant women who participated in Pfizer’s mRNA COVID vaccine trial suffered miscarriages, according internal Pfizer documents, recently released under court order. Despite this, Pfizer, and the Biden administration insisted that the vaccines were safe for pregnant women. Out of 50 pregnant women, 22 of them lost their babies, according to an analysis of the documents.

Read More

New Government Spending Will Benefit Top Biden Adviser’s Consulting Clients

White House Senior adviser Anita Dunn has consulted for companies and trade groups that have benefited or stand to benefit from federal funding and is being forced to recuse herself from matters involving them, according to a financial disclosure.

Dunn has consulted through the public affairs firm SKDK during the past two years for the likes of Pfizer, AT&T, Micron and the American Clean Power Association, according to a filing reported on by CNBC Friday. Dunn, who founded the SKDK in 2004, is recused from working on issues related to past clients, a spokesman for the White House told the Daily Caller News Foundation.

Read More

Ivy League Study: Boosters, COVID-19 ‘Rebounds’ Fuel Skepticism of Federal Narratives

As the nation’s most powerful and twice-boosted infectious disease doctor battles a COVID-19 “rebound” two weeks after testing positive, new research from the public health schools at Harvard and Yale suggests the boosted fared worse against the first Omicron subvariant than the non-boosted.

The FDA is so alarmed by the “waning effectiveness” of boosters, whose formulation is still based on the ancestral Wuhan strain, that it asked manufacturers Thursday to add a “spike protein component” from the fourth and fifth Omicron subvariants to this fall’s boosters.

Read More

Peer-Reviewed Paper Shows Significant Fertility Risks for Men Who Get the Pfizer COVID Vaccine

A peer-reviewed paper released on Friday shows large decreases in sperm counts among men after the second dose of Pfizer’s mRNA COVID vaccine, with the decline continuing for over five months in many cases.

The study, published in the medical journal Andrology, confirms that the mRNA shots have significant fertility risks for men, independent journalist Alex Berenson reported on his Unreported Truths Substack.

Read More

Whisteblower’s Lawyer: Pfizer Got Away with Vaccine Fraud Because Government Was Co-Conspirator

Pfizer has asked a U.S. court to throw out a whistleblower’s lawsuit on the basis that the company can’t be guilty of fraud, abuse, and protocol violations in its COVID Vaccine clinical trials because its contract with the U.S. government allowed them to skirt regulations and federal laws that typically apply to government contracts.

Read More

Doctor Crashes FDA Meeting and Shares the Whistleblower Story They Ignored

A doctor “crashed” a Food and Drug Administration’s meeting with outside vaccine experts earlier this week, to share a whistleblower’s story about the data integrity issues that plagued one of Pfizer’s clinical trials.

In September of 2020, a researcher from an organization testing Pfizer’s vaccine at several sites in Texas, emailed a complaint to the FDA, informing the agency of the company’s dangerously shoddy research practices. The FDA took no action on her email, and Pfizer continues to use the company.

Read More

Newly Released Docs: Pfizer Had to Hire 1,800 Additional Employees in Early 2021 to Process ‘Large Increase’ in Vaccine Adverse Events

Pfizer hired 1,800 additional full-time employees in the first half of 2021 to deal with “the large increase” of adverse reactions to its COVID vaccine, newly released secret documents reveal. The Pfizer-BioNTech COVID-19 Vaccine was made available under the Emergency Use Authorization (EUA) on Dec. 11, 2020. By February of 2021, the company was seeing so many safety signals, including in pregnant and breastfeeding mothers, it had to immediately hire 600 employees to process the data.

Read More

Pfizer CEO Calls for Another Booster Shot for All Americans

On Sunday, the chief executive officer of Pfizer said that Americans should be prepared to receive a second booster shot of the Coronavirus vaccine, which would mark the fourth overall shot that has been forced on the American public.

As reported by Politico, Albert Bourla made his remarks in an interview with CBS’ Margaret Brennan, where he said that his company was preparing to submit “a significant package of data about the need for a fourth dose” to the Food and Drug Administration (FDA).

Read More

Trans Activists Funded by Big Pharma Push Biased Research Promoting Medical Transitions for Children

Researchers are churning out biased studies promoting medical gender transitions for children, often supported by pharmaceutical companies and activist organizations, and the media frequently promotes the conclusions uncritically.

A March 2021 National Institute for Health and Care Excellence comprehensive review of nine studies failed to find evidence that hormonal therapy and puberty blockers were helpful. The review pointed out common flaws in transgender treatment research, such as confounding variables and bias resulting from observational studies that lack control groups.

Read More